Amyris Returns to Sweeteners With Deal to Acquire Sweet Protein Maker Oobli

Amyris, a US biomanufacturer based in Emeryville, has announced its acquisition of Oobli, a California company specializing in sweet proteins produced through precision fermentation. This deal, expected to close in the coming weeks, aims to combine Oobli's sweet protein portfolio and fermentation expertise with Amyris' capabilities in strain engineering and manufacturing. Production will remain with Oobli's current contract manufacturer for the time being, ensuring existing customer commitments and brand partnerships are uninterrupted.

Oobli offers three natural sweet proteins—Oubli Fruit, Serendipity Berry, and Katemfe Fruit Sweet Proteins—known for being hundreds to thousands of times sweeter than sugar without causing blood sugar spikes. The proteins have received FEMA GRAS affirmation and FDA “no questions” letters for regulatory approval. Amyris's acquisition marks a return to the sugar reduction market after dissolving its previous joint venture. Both companies anticipate that combining their strengths will broaden their capabilities across various sectors, including food and beverage, personal care, and agriculture, ultimately positioning sweet proteins as a leading choice in sweetness solutions globally.